Post Profile

Risk factors for DKA in patients taking SGLT2 inhibitors

p { margin-bottom: 0.1in; line-height: 120%; }a:link { } The use of SGLT2 inhibitors has been associated with DKA in patients with type 2 diabetes. This review examined risk factors for its development. From the paper: Patients Thirty-four case reports of patients with type 1 and type 2 diabetes mellitus who developed DKA while receiving an SGLT2i. Methods
read more


Related Posts

SGLT2 inhibitors for DM 2 reduce blood pressure

Industries / Medical : Notes from Dr. RW

p { margin-bottom: 0.1in; line-height: 120%; }a:link { } A systemic review and meta-analysis.

Eye and heart complications are tightly linked in type 1 diabetes

Diseases & Conditions / Diabetes : ScienceDaily: Diabetes

People with chronic kidney disease have much higher risk of cardiovascular disease, the leading cause of death for those with type 1 diabetes. In a new article researchers demonstrated that the eye condition known as proliferative d...

Do SGLT-2 Inhibitors for Type 2 Diabetes Raise Cancer Risk?

Diseases & Conditions / Diabetes : Diabetes Daily

SGLT-2 inhibitors are a class of type 2 diabetes drugs that have shown a link for raising one’s cancer risk. SGLT2 drugs lower blood sugar by blocking the reabsorption of glucose in the kidneys, allowing them to excrete this excess ...

Study: SGLT-2 Inhibitors Raise Risk of Diabetic Ketoacidosis

Diseases & Conditions / Diabetes : Diabetes Daily

In an article published in the New England Journal of Medicine researchers explain that their study suggests sodium-glucose cotransporter 2 (SGLT2) drugs for type 2 diabetes may increase the risk for diabetic ketoacidosis (DKA). SGL...

SGLT2 inhibitors associated with no more DKA than other drugs in an insurance database

Industries / Medical : Notes from Dr. RW

p { margin-bottom: 0.1in; line-height: 120%; }a:link { } From the study: Highlights Overall, unadjusted DKA incidence were similar between SGLT2 and non-SGLT2 agents. Overall, unadjusted DKA incidence dropped by ?50% when excluding ...


Copyright © 2016 Regator, LLC